-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicide-prevention_disposition-comments.pdf
October 04, 2016 - The tables and information
provided are thorough and detailed. … Detailed guidelines on
the technical and legal aspects of data
linkage could be developed to facilitate
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/improved-cancer-outcomes-protocol_0.pdf
December 01, 2021 - Nutrition as Prevention for Improved Cancer Outcomes
Evidence-based Practice Center Systematic Review Protocol
Project Title: Nutrition as Prevention for Improved Cancer Outcomes
I. Background
Among adults with cancer, malnutrition is associated with worse survival, decreased
treatment co…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
April 01, 2012 - Affiliation Section Comment Response
Peer Reviewer
#3
Methods The problem with the search strategies is detailed … This is further detailed in my
response to Key
We have added text describing the cross-sectional studies … Affiliation Section Comment Response
Public
comment/
AAO-AGS
Results Key Question 1- Page 38
detailed … Other procedures (but not all
available procedures) are discussed in the detailed analysis of
primary
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_10-user-guide-to-ocer_130129.pdf
January 01, 2011 - 135
Abstract
This chapter provides a high-level overview of statistical analysis considerations for observational
comparative effectiveness research (CER). Descriptive and univariate analyses can be used to assess
imbalances between treatment groups and to identify covariates associated with exposure and/or the stu…
-
effectivehealthcare.ahrq.gov/products/pelvic-pain/research-protocol
October 19, 2010 - require that studies include at least one outcome measure (regardless of validation) for an outcome detailed … Full text review forms are somewhat more detailed and intended to assist in a) identifying studies that … Decision rules regarding detailed use of the quality assessment tools will be specified a priori by the
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
January 01, 2011 - Analytic Framework
Please see the KQs for detailed study eligibility criteria. … Inclusion/exclusion criteria for study design are detailed
below. … methodological quality, or risk of biases, for each individual study by
using the assessment instrument detailed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
April 25, 2013 - 25, 2013
17
Commentator &
Affiliation Section Comment Response
TEP Member 6 Results The detailed … TEP Member 7 Results The section is very detailed and clearly described. … A better approach may be to keep the
summary document and then refer the reader to more detailed
review … Public Reviewer -
ACCP 10
General Regarding the KQ1 and 2 more detailed discussion again I found … A very detailed document but does not quite address the
questions that are clinically pertinent.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-vibration-therapy_disposition-comments.pdf
November 15, 2011 - Peer Reviewer #1 Findings The evidence tables provide detailed and essential information of the
studies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/women-hiv_disposition-comments.pdf
November 21, 2016 - This data is
significant as it provides a more detailed picture of the
epidemic in this particular … We also added a paragraph in the discussion,
limitations section: We did not conduct a
detailed analysis … Similarly, we did not do a
detailed analysis of the risk of bias or the
strength of evidence of individual
-
effectivehealthcare.ahrq.gov/sites/default/files/calcineurin-inhibitor_disposition-comments.pdf
March 15, 2016 - Because of the limitations of the available data, at
times the summary was not much more detailed than … We
refer to this consideration in
the detailed synthesis of the
Results Section for Key
Question
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - More detailed descriptions of approaches to
analyzing medication compliance and persistence
using retrospective … For example, hospital billing data
will usually not include detailed information on
the medications
-
effectivehealthcare.ahrq.gov/products/public-reporting-cost-measures/research-protocol
January 13, 2014 - We will include such practices when they are detailed in the literature or are indirectly identified, … Our preliminary search strategy is detailed in Appendix 3 .
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/could-the-cost-of-additional-staffing-and-techniques-utilizing-lesser-restrictive-interventions-with-pyschiatric-patients-provide-an-overall-reduction-of-spending-for-institutions-versus-total-spending-with-current-use-of-sec
August 14, 2012 - Home »
Get Involved »
Nominated Topics »
Topic Suggestion Description
Topic Suggestion Description
Date submitted: August 14, 2012
Download Topic Suggestion Disposition [PDF · 1.2 MB]
Briefly describe a specific question, or set of related questions, about a health c…
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-pku-there-is-now-a-pharmaceutical-drug-to-treat-this-condition-in-the-past-is-was-treated-by-medical-foods-that-eliminated-the-harmful-substance-phenylalanine-the-cost-of-the-new-drug-is-70k-year-the-cost-to
June 17, 2009 - Home »
Get Involved »
Nominated Topics »
Topic Suggestion Description
Topic Suggestion Description
Date submitted: June 17, 2009
Download Topic Suggestion Disposition [PDF · 102.9 KB]
Briefly describe a specific question, or set of related questions, about a health c…
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/evidence-based-treatment-for-pressure-ulcers-by-stage
September 22, 2010 - Home »
Get Involved »
Nominated Topics »
Topic Suggestion Description
Topic Suggestion Description
Date submitted: September 22, 2010
Download Topic Suggestion Disposition [PDF · 125.6 KB]
Briefly describe a specific question, or set of related questions, about a hea…
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-renal-of-differnt-contrast-media-used-in-radiographic-imaging-what-is-the-comparative-efficacy-of-different-therapies-in-preventing-contrast-induced-nephropathy
December 30, 2011 - Home »
Get Involved »
Nominated Topics »
Topic Suggestion Description
Topic Suggestion Description
Date submitted: December 30, 2011
Download Topic Suggestion Disposition [PDF · 48.1 KB]
Briefly describe a specific question, or set of related questions, about a healt…
-
effectivehealthcare.ahrq.gov/products/osteoporosis-bone-fracture/research-protocol
May 14, 2010 - Current Page Topic Timeline Feb. 12, 2010 Topic Initiated May. 14, 2010 Research Protocol Mar. 28, 2012 Systematic Review Jun. 28, 2012 Disposition of Comments Report Sep. 2, 2016 Surveillance Report Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis – …
-
effectivehealthcare.ahrq.gov/products/transparency-mental-health/research
January 06, 2017 - Supplemental Project To Assess the Transparency of Reporting for Strategies To Improve Mental Health Care for Children and Adolescents
Research Report January 6, 2017 Web Version [NLM Site] Download Main Document PDF 167.2 KB
People using assistive technology may not be able to fully access information …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cesarean-birth-2010_executive.pdf
January 01, 2010 - inconsistent reporting of
multiple adverse effects
13
taken care to indicate when this is the case in the detailed … Detailed research in the
context of multisite trials is warranted to more carefully
parse which tools
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_research-protocol.pdf
January 13, 2014 - We will include such practices when they are detailed in the literature or are
indirectly identified … Our preliminary search strategy is detailed in Appendix 3.